Osaka
Japan
30
2016-09-01
25
2018-02-13
These are the the leading inventors for applications assigned to ANGES MG, INC.:
ANGES MG, INC. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
#2 | 2016-03-31 β Patent 9,889,186 granted on 2018-02-13Oral vaccine having improved cellular immunity induction potency
#3 | 2015-05-14 β Patent 9,695,219 granted on 2017-07-04Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
#4 | 2015-04-21 β Patent 9,012,417 granted on 2015-04-21Topical administration of NF-kappaB decoy to treat atopic dermatitis
#5 | 2012-07-05 β Patent 8,969,311 granted on 2015-03-03Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
#6 | 2012-03-01 β Patent 8,470,765 granted on 2013-06-25Polypeptides and antibacterial or antiseptic use of same
#7 | 2011-10-13 β Patent 8,647,820 granted on 2014-02-11Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
#8 | 2011-01-27 β Patent 9,186,439 granted on 2015-11-17Drug-eluting catheter and method of manufacturing the same
#9 | 2011-01-18 β Patent 7,871,983 granted on 2011-01-18Remedy and preventive for diseases caused by NF-ΞΊB
#10 | 2010-12-30 β Patent 8,067,388 granted on 2011-11-29Decoy-containing pharmaceutical compositions and method of using the same
#11 | 2010-09-23 β Patent 7,994,151 granted on 2011-08-09Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
#12 | 2009-03-26DRUG AND METHOD FOR IMPROVING BRAIN FUNCTION
#13 | 2009-03-05 β Patent 7,897,751 granted on 2011-03-01Pharmaceutical preparation
#14 | 2008-08-28Decoy compositions for treating and preventing brain diseases and disorders
#15 | 2007-11-15 β Patent 7,939,504 granted on 2011-05-10Method of treating skin ulcers with vectors encoding hepatocyte growth factor
#16 | 2007-11-08 β Patent 8,067,384 granted on 2011-11-29Chimera (double) decoy
#17 | 2007-10-23 β Patent 7,285,540 granted on 2007-10-23Medicament comprising HGF gene
#18 | 2007-10-09 β Patent 7,279,333 granted on 2007-10-09Virus envelope vector for gene transfer
#19 | 2007-06-21 β Patent 7,524,830 granted on 2009-04-28Decoy-containing pharmaceutical compositions and method of using the same
#20 | 2006-12-07 β Patent 7,595,301 granted on 2009-09-29Staple type oligonucleotide and drug comprising the same
#21 | 2006-11-23Pharmaceutical composition containing decoy and use of the same
#22 | 2006-10-26 β Patent 7,345,158 granted on 2008-03-18Actin related cytoskeletal protein βLACSβ
#23 | 2006-07-27 β Patent 7,427,395 granted on 2008-09-23Chemotherapeutic agent-incorporated pharmaceutical preparation
#24 | 2006-07-13 β Patent 7,585,848 granted on 2009-09-08Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
#25 | 2006-06-22 β Patent 7,259,149 granted on 2007-08-21Methods for treating or preventing angiogenesis-dependent symptoms
#26 | 2006-06-22Method for culturing neural stem cells using hepatocyte growth factor
#27 | 2006-01-05 β Patent 7,504,098 granted on 2009-03-17Method for introducing a biological molecule using a viral envelope and heparin and system therefore
#28 | 2005-11-24 β Patent 7,790,692 granted on 2010-09-07Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival
#29 | 2005-10-27 β Patent 7,803,621 granted on 2010-09-28Virus envelope vector for gene transfer
#30 | 2005-08-30 β Patent 6,936,594 granted on 2005-08-30Gene therapy for cerebrovascular disorders
Also check out ANGES MG, INC.'s (Osaka, Japan) applicant profile with 1 patent applications submitted.
92501 β